Cargando…

Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer

BACKGROUND: BRCA mutations are the main known hereditary factor for ovarian cancer. Notably, emerging evidence indicates that the glucocorticoid receptor (GR) has drawn considerable interest in ovarian cancer development. However, dynamic cross-talk between BRCA1 and GR signaling pathways are poorly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Yuan-Yuan, Li, Da, Cao, Chen, Li, Chun-Yan, Li, Ting-Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004164/ https://www.ncbi.nlm.nih.gov/pubmed/24629067 http://dx.doi.org/10.1186/1471-2407-14-188

Ejemplares similares

Effect of BRCA1 on epidermal growth factor receptor in ovarian cancer
por: Li, Da, et al.
Publicado: (2013)

Regulation of angiotensin II type 1 receptor expression in ovarian cancer: a potential role for BRCA1
por: Bi, Fang-Fang, et al.
Publicado: (2013)

Cryptochromes mediate rhythmic repression of the glucocorticoid receptor
por: Lamia, Katja A., et al.
Publicado: (2011)

Epigenetic repression of phosphatidylethanolamine N-methyltransferase (PEMT) in BRCA1-mutated breast cancer
por: Li, Da, et al.
Publicado: (2014)

A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer
por: Li, Da, et al.
Publicado: (2014)

Kaiso represses the expression of glucocorticoid receptor via a methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells
por: Zhou, Lin, et al.
Publicado: (2016)

PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer
por: Hong, Ting, et al.
Publicado: (2021)

Glucocorticoid receptor-mediated cis-repression of osteogenic genes requires BRM-SWI/SNF()
por: Pico, Michael J., et al.
Publicado: (2016)

BRCA1 affects the resistance and stemness of SKOV3‐derived ovarian cancer stem cells by regulating autophagy
por: You, Yue, et al.
Publicado: (2019)

CtBP determines ovarian cancer cell fate through repression of death receptors
por: Ding, Boxiao, et al.
Publicado: (2020)

BRCA1-mediated repression of select X chromosome genes
por: Jazaeri, Amir A, et al.
Publicado: (2004)

BRCA1 regulates insulin-like growth factor 1 receptor levels in ovarian cancer
por: LIU, BO, et al.
Publicado: (2014)

AMPK Mediates Glucocorticoids Stress-Induced Downregulation of the Glucocorticoid Receptor in Cultured Rat Prefrontal Cortical Astrocytes
por: Yuan, Shi-Ying, et al.
Publicado: (2016)

Timing Is Critical for Effective Glucocorticoid Receptor Mediated Repression of the cAMP-Induced CRH Gene
por: van der Laan, Siem, et al.
Publicado: (2009)

Repression of the Glucocorticoid Receptor Aggravates Acute Ischemic Brain Injuries in Adult Mice
por: Li, Yong, et al.
Publicado: (2018)

BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
por: Stefansson, Olafur A., et al.
Publicado: (2012)

Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53
por: Quinn, Bridget A., et al.
Publicado: (2009)

Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer
por: KUANG, YAN, et al.
Publicado: (2013)

Repression of the Glucocorticoid Receptor Increases Hypoxic-Ischemic Brain Injury in the Male Neonatal Rat
por: Knox-Concepcion, Katherine R., et al.
Publicado: (2019)

The DNA Binding-Independent Function of the Glucocorticoid Receptor Mediates Repression of Ap-1–Dependent Genes in Skin
por: Tuckermann, Jan P., et al.
Publicado: (1999)

Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era
por: Gerber, Anthony N., et al.
Publicado: (2021)

Gene-specific mechanisms direct glucocorticoid-receptor-driven repression of inflammatory response genes in macrophages
por: Sacta, Maria A, et al.
Publicado: (2018)

PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer
por: Yeerken, Danna, et al.
Publicado: (2020)

Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention
por: Buonaiuto, Roberto, et al.
Publicado: (2023)

Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51
por: Tao, Lei, et al.
Publicado: (2023)

Poly (ADP-ribose) polymerase 1 transcriptional regulation: A novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1-mutated ovarian cancer
por: Li, Da, et al.
Publicado: (2013)

The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP
por: Yue, Wei, et al.
Publicado: (2022)

The glucocorticoid receptor represses, whereas C/EBPβ can enhance or repress CYP26A1 transcription
por: Yoo, Hong Sik, et al.
Publicado: (2022)

Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
por: Lee, Chee Khoon, et al.
Publicado: (2019)

Glucocorticoid receptors in the locus coeruleus mediate sleep disorders caused by repeated corticosterone treatment
por: Wang, Zi-Jun, et al.
Publicado: (2015)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
por: Manchana, Tarinee, et al.
Publicado: (2020)

The BRCA Gene in Epithelial Ovarian Cancer
por: Sánchez-Lorenzo, Luisa, et al.
Publicado: (2022)

Characterization of BRCA Deficiency in Ovarian Cancer
por: Barbero, Giovanna, et al.
Publicado: (2023)

Glucocorticoid receptor represses brain-derived neurotrophic factor expression in neuron-like cells
por: Chen, Hui, et al.
Publicado: (2017)

Glucocorticoid counteracts cellular mechanoresponses by LINC01569-dependent glucocorticoid receptor–mediated mRNA decay
por: Zhu, Huayu, et al.
Publicado: (2021)

Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
por: Zhang, Yunuo, et al.
Publicado: (2022)

Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations
por: Birkbak, Nicolai Juul, et al.
Publicado: (2013)

Mutational analysis of BRCA1 and BRCA2 in northwest Chinese breast cancer patients
por: Wang, Ting, et al.
Publicado: (2019)

Repression of major histocompatibility complex IA expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein
Publicado: (1993)

Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers
por: Arakelyan, Arsen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fr6bi8kmrnqune4jbsdi0em4m3